<p>(A) Cells were treated with a series of concentrations of 10 nm AgNPs, 100 nm AgNPs or Ag<sup>+</sup> for 24 hours, and the samples were analyzed with dual-phospho-ERK (Thr202/Tyr204) antibody, ERK antibody, dual-phospho-p38 (Thr180/Tyr182) antibody, p38 antibody, dual-phospho-JNK (Thr183/Tyr185) antibody and JNK antibody, respectively, using western blot. β-actin was used for equal loading. The panel shows images representative of three independent experiments. (B, C, D) The intensity of each chemiluminescence protein band was analyzed by ImageJ and normalized to the MAPKpp/β-actin ratio (control = 1), with the data expressed as mean ± S.D. (n = 3), *<i>p</i><0.05.</p
<p>A) Untreated HeLa cells, or cells pre-treated with the specific p38 MAPK inhibitor SB203580 (20 μ...
<p><b>A:</b> Dose response and time course of phosphate-activated MAPK in S2R+ cells. <b>B:</b> Dose...
<p><b>A:</b> Immunoblot for pERK/MAPK in GT1-7 and SCN2.2 cells treated with media change (control) ...
<p>The upper side of panel (A) shows a representative Western blot for Phospho-p44/42 MAPK (Erk1/2) ...
<p>(A) The proteins ERK, p-ERK, p38, p-p38, JNK and p-JNK were determined using western blotting wit...
<p>phosphorylated p38 (phospho- p38) and total p38 MAPK, phosphorylated JNK MAPK (phospho-JNK MAPK) ...
<p>(A) Cells were pretreated with 10 mM NAC for 2 hours prior to 24 hours exposure with a series of ...
<p>Panel A: The p38<sup>MAPK</sup> inhibitor SB203580 (10 µM) reversed the antiproliferative effect ...
<p>(A):effects of exposure to 0,25 µM doxorubicin on MAPK activation by western blot using antibodie...
<p>Cells were incubated with GrK (200 nM) for 10 min, 30 min, or 2 h. Cell lysates were collected an...
<p>(A) Levels of phosphorylated-JNK were analyzed by immunoblot after CDDP exposure (IC<sub>50</sub>...
<p>AGS <b>(A)</b> and MKN45 <b>(B)</b> cells were treated with rJHP0290 for various time points (min...
<p>(A) Cells were exposed to 1.0 mg/L of 10 nm AgNPs, 100 nm AgNPs or Ag<sup>+</sup> for various tim...
<p>(A) Cells were exposed to different concentrations of 10 nm AgNPs, 100 nm AgNPs or Ag<sup>+</sup>...
<p>A. SK-N-SH cells were treated with 200 µM of PrP106–126, scrambled peptide PrP106–126 (SCR) or DM...
<p>A) Untreated HeLa cells, or cells pre-treated with the specific p38 MAPK inhibitor SB203580 (20 μ...
<p><b>A:</b> Dose response and time course of phosphate-activated MAPK in S2R+ cells. <b>B:</b> Dose...
<p><b>A:</b> Immunoblot for pERK/MAPK in GT1-7 and SCN2.2 cells treated with media change (control) ...
<p>The upper side of panel (A) shows a representative Western blot for Phospho-p44/42 MAPK (Erk1/2) ...
<p>(A) The proteins ERK, p-ERK, p38, p-p38, JNK and p-JNK were determined using western blotting wit...
<p>phosphorylated p38 (phospho- p38) and total p38 MAPK, phosphorylated JNK MAPK (phospho-JNK MAPK) ...
<p>(A) Cells were pretreated with 10 mM NAC for 2 hours prior to 24 hours exposure with a series of ...
<p>Panel A: The p38<sup>MAPK</sup> inhibitor SB203580 (10 µM) reversed the antiproliferative effect ...
<p>(A):effects of exposure to 0,25 µM doxorubicin on MAPK activation by western blot using antibodie...
<p>Cells were incubated with GrK (200 nM) for 10 min, 30 min, or 2 h. Cell lysates were collected an...
<p>(A) Levels of phosphorylated-JNK were analyzed by immunoblot after CDDP exposure (IC<sub>50</sub>...
<p>AGS <b>(A)</b> and MKN45 <b>(B)</b> cells were treated with rJHP0290 for various time points (min...
<p>(A) Cells were exposed to 1.0 mg/L of 10 nm AgNPs, 100 nm AgNPs or Ag<sup>+</sup> for various tim...
<p>(A) Cells were exposed to different concentrations of 10 nm AgNPs, 100 nm AgNPs or Ag<sup>+</sup>...
<p>A. SK-N-SH cells were treated with 200 µM of PrP106–126, scrambled peptide PrP106–126 (SCR) or DM...
<p>A) Untreated HeLa cells, or cells pre-treated with the specific p38 MAPK inhibitor SB203580 (20 μ...
<p><b>A:</b> Dose response and time course of phosphate-activated MAPK in S2R+ cells. <b>B:</b> Dose...
<p><b>A:</b> Immunoblot for pERK/MAPK in GT1-7 and SCN2.2 cells treated with media change (control) ...